Rising application of cellular health screening in personalized medicine, increasing global geriatric population, and growing awareness about cellular biomarkers are key factors driving market growth
New York, January 20,2022- The global cellular health screening market size is expected to reach USD 6.23 billion by 2028 at a CAGR of 10.3%, according to the latest report by Reports and Data. Increasing global burden of chronic diseases, growing importance of cellular health screening, and rising focus on preventive healthcare are key factors expected to drive market revenue growth over the forecast period. In addition, increasing research on cellular biomarkers, rapid adoption of direct-to-customer approaches, and growing application of cellular health screening in precision medicine are expected to contribute to revenue growth of the market going ahead.
Cellular health plays a pivotal role in offering information about health conditions of an individual. Cellular health screening offers a comprehensive overview of patients’ health at a cellular level and enables healthcare practitioners and physicians identify areas that require support to develop personalized treatment plans. The test is primarily used to examine inflammatory conditions such as allergies, asthma, arthritis, and certain autoimmune conditions. It can also be used to monitor body’s response to personalized treatment approaches. The tests are non-invasive and are recommended when a person wants to boost energy levels, improve health and fitness, lose weight, and achieve muscle toning. Growing awareness about healthy lifestyle and increasing focus on preventive healthcare measures are expected to further fuel market growth over the forecast period.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4020
Increasing research and development activities to produce novel drugs and supplements to boost cellular health and growing number of preclinical studies worldwide are some other key factors driving market growth. In addition, growing adoption of telomere performance programs owing to increasing awareness about crucial role of telomeres in cellular health is expected to fuel market growth over the forecast period. However, risks associated with transportation of samples and high costs of kits are expected to hamper market growth to a certain extent during the forecast period.
Some Key Highlights from the Report:
- Single-test panel segment is expected to account for largest share in terms of revenue, which is attributable to increasing need to screen for individual biomarkers and obtain accurate information about risk of diseases.
- Blood sample segment is expected to register significant revenue growth over the forecast period owing to rising adoption of direct-to-customer approach and advantages such as easy sample collection and accurate and reliable test results.
- Hospitals segment is expected to account for significant revenue share in the global market over the forecast period owing to abundance of skilled healthcare professionals, integration of cellular health screening in routine checkup, and convenient and safe testing.
- North America is expected to account for largest revenue share in the global market owing to growing awareness about benefits of healthy lifestyle, increasing adoption of cellular health screening, rising prevalence of chronic diseases, and increasing focus of governments on preventive healthcare in the region.
- Key companies in the market include Genova Diagnostics, Telomere Diagnostics, Life Length, Quest Diagnostics, Repeat Diagnostics, SpectraCell Laboratories, Zimetry LLC, Cell Science Systems, Titanovo, Inc., Segterra, Inc., LabCorp Holdings, BioReference Laboratories, Immundiagnostik AG, and Cleveland HeartLab, Inc., among others.
To know more about the report @ https://www.reportsanddata.com/report-detail/cellular-health-screening-market
For the purpose of this report, Reports and Data has segmented the cellular health screening market based on type, sample type, sample collection site, and region:
Type Outlook (Revenue, USD Billion; 2018-2028)
- Single-test Panels
- Telomere Tests
- Oxidative Stress Tests
- Inflammation Tests
- Heavy Metal Tests
- Multi-test Panels
Sample Type Outlook (Revenue, USD Billion; 2018-2028)
- Blood
- Urine
- Saliva
- Serum
- Others
Sample Collection Site Outlook (Revenue, USD Billion; 2018-2028)
- At-home
- In-office
- Hospitals
- Diagnostic Laboratories
Buy Premium Research Report @ https://www.reportsanddata.com/checkout-form/4020
Regional Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/4020
Some points on how the report benefits stakeholders:
- The reports include historical (2018–2020) and forecast (2021–2028) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2018 and 2028.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Respiratory Inhaler Devices Market Size, Share & Analysis, By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), By Mode of Operation (Digitally Operated Inhaler Devices), By Application (Chronic Obstructive Pulmonary Disease, Asthma), And By Region, Forecast To 2027
Hyperbaric Oxygen Therapy Device Market Size, Share & Analysis, By Product Type (Mono-place HBOT Devices, Multi-place HBOT Devices, Topical HBOT Devices), By Application (Wound Healing, Decompression Sickness, Infections, Gas Embolism, Others), And By Region, Forecast To 2028
Compound Management Market Size, Share & Analysis, By Type (Automated Compound/Sample Storage Systems, Automated Liquid Handling Systems, Outsourcing Services, Others), By Sample Type (Chemical Compounds, Biological Samples, Others), By Application (Drug Discovery, BioBanking, Gene Synthesis, Others), By End-use (Pharmaceutical Companies, Biopharmaceutical Companies, Research and Academic Institutes, Contract Research Organizations (CROs), Others), and By Region Forecast to 2028
Botulism Market By Type (Infant, Inhalation, Foodborne, Wound, Others), By Toxin Type (Type A, Type B), By Treatment (Antibiotics, Antitoxin, Cathartics, Meticulous Airway Management, Others), By Distribution Channel (Hospital Pharmacies, Online Shops, Retail Pharmacies, Others), and By Region Forecast to 2028
Vacutainer Market By Product Type (Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, and Others), By Material (Glass, Plastic), By End-Use (Diagnostic Centers, Healthcare Centers, Research and Development Centers), And By Region Forecast to 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-cellular-health-screening-market